IDGXF
Price:
$0.59465
Market Cap:
$15.73B
Integrated Diagnostics Holdings plc (IDGXF) functions as a consumer-focused healthcare enterprise, primarily dedicated to providing a comprehensive array of medical diagnostic services for patients. Its extensive service portfolio encompasses approximately 2,000 distinct diagnostic examinations, spanning diverse fields such as immunology, microbiology, hematology, endocrinology, clinical chemistry, molecular biology, cytogenetics, histopathology, and radiology. The company maintains an operational footprint across Egypt, Jordan, Sudan, and Nigeria. By December 30, 2021, its network had grown to encompass 452 branch laboratories. Established in 1979, the organization's main office is situated...[Read more]
Industry
Medical - Diagnostics & Research
IPO Date
2019-06-03
Stock Exchange
OTC
Ticker
IDGXF
According to Integrated Diagnostics Holdings plc’s latest financial reports and current stock price. The company's current ROE is 42.26%. This represents a change of 509.36% compared to the average of 6.94% of the last 4 quarters.
The mean historical ROE of Integrated Diagnostics Holdings plc over the last ten years is 27.56%. The current 42.26% ROE has changed 53.35% with respect to the historical average. Over the past ten years (40 quarters), IDGXF's ROE was at its highest in in the September 2021 quarter at 18.82%. The ROE was at its lowest in in the September 2022 quarter at -1.82%.
Average
27.56%
Median
24.09%
Minimum
11.64%
Maximum
54.69%
Discovering the peaks and valleys of Integrated Diagnostics Holdings plc ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 109.00%
Maximum Annual ROE = 54.69%
Minimum Annual Increase = -54.07%
Minimum Annual ROE = 11.64%
| Year | ROE | Change |
|---|---|---|
| 2025 | 37.31% | -6.15% |
| 2024 | 39.76% | 108.70% |
| 2023 | 19.05% | -24.17% |
| 2022 | 25.12% | -54.07% |
| 2021 | 54.69% | 109.00% |
| 2020 | 26.17% | 13.47% |
| 2019 | 23.06% | 4.26% |
| 2018 | 22.12% | 32.79% |
| 2017 | 16.66% | 43.10% |
| 2016 | 11.64% | 52.29% |
The current ROE of Integrated Diagnostics Holdings plc (IDGXF) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
32.04%
5-year avg
35.19%
10-year avg
27.56%
Integrated Diagnostics Holdings plc’s ROE is greater than iSpecimen Inc. (-584.67%), greater than Star Equity Holdings, Inc. (-13.56%), greater than bioAffinity Technologies, Inc. (-358.76%), greater than Applied DNA Sciences, Inc. (-337.10%), greater than Sera Prognostics, Inc. (-41.02%), greater than Precipio, Inc. (-6.73%), greater than Genetic Technologies Limited (-184.98%), less than MDxHealth S.A. (402.97%), greater than Star Equity Holdings, Inc. (-13.56%), greater than Standard BioTools Inc. (-20.80%), greater than Genetron Holdings Limited (-100.92%), greater than Biodesix, Inc. (-2101.40%), greater than ENDRA Life Sciences Inc. (-513.22%), greater than HTG Molecular Diagnostics, Inc. (-273.49%), greater than Intelligent Bio Solutions Inc. (-174.16%), greater than bioAffinity Technologies, Inc. (-358.76%), less than SeqLL Inc. (274.33%), less than Interpace Biosciences, Inc. (215.31%), greater than Neuronetics, Inc. (-164.68%), greater than ProPhase Labs, Inc. (-157.67%),
| Company | ROE | Market cap |
|---|---|---|
| -584.67% | $381.87K | |
| -13.56% | $40.80M | |
| -358.76% | $6.71M | |
| -337.10% | $7.26M | |
| -41.02% | $71.42M | |
| -6.73% | $39.50M | |
| -184.98% | $111.24M | |
| 402.97% | $27.85M | |
| -13.56% | $40.80M | |
| -20.80% | $346.53M | |
| -100.92% | $127.29M | |
| -2101.40% | $122.59M | |
| -513.22% | $3.43M | |
| -273.49% | $1.06M | |
| -174.16% | $1.55M | |
| -358.76% | $6.46M | |
| 274.33% | $2.51M | |
| 215.31% | $44.32M | |
| -164.68% | $92.55M | |
| -157.67% | $378.96K |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Integrated Diagnostics Holdings plc using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Integrated Diagnostics Holdings plc or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Integrated Diagnostics Holdings plc's ROE?
How is the ROE calculated for Integrated Diagnostics Holdings plc (IDGXF)?
What is the highest ROE for Integrated Diagnostics Holdings plc (IDGXF)?
What is the 3-year average ROE for Integrated Diagnostics Holdings plc (IDGXF)?
What is the 5-year average ROE for Integrated Diagnostics Holdings plc (IDGXF)?
How does the current ROE for Integrated Diagnostics Holdings plc (IDGXF) compare to its historical average?